INSIDE INDUSTRY.
In: Asia Pacific Biotech News, Jg. 21 (2017-03-01), Heft 3, S. 31-37
serialPeriodical
Zugriff:
Mundipharma and Helsinn Group Expand Exclusive Licensing and Distribution Agreements for Leading Anti-emetic Products in Middle East, Africa, Latin America and Indonesia. Leading Regional Medical Technology Trade Associations Reinforce their Commitment to Evidence-based Healthcare. Lonza Expands Airway Disease Portfolio with Addition of IPF Airway Cells. Boston Scientific Launches Interventional Cardiology Online Education Portal for Physicians. Pfizer Presented Data from PALOMA-2 Phase 3 Study Demonstrating Clinical Benefit of IBRANCE ® (palbociclib) in Asian Women with ER+, HER2- Metastatic Breast Cancer. Global Healthcare Systems at Pivotal Point as Technology Offers Solutions to Industry Challenges - The Economist Intelligence Unit. Cellectricon and Censo Biotechnologies Introduce a Joint Technology Access Program Utilizing High-Quality Human iPSC-based Discovery Services for CNS and Pain Research. [ABSTRACT FROM AUTHOR]
Copyright of Asia Pacific Biotech News is the property of World Scientific Publishing Company and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
INSIDE INDUSTRY.
|
---|---|
Zeitschrift: | Asia Pacific Biotech News, Jg. 21 (2017-03-01), Heft 3, S. 31-37 |
Veröffentlichung: | 2017 |
Medientyp: | serialPeriodical |
ISSN: | 0219-0303 (print) |
DOI: | 10.1142/S0219030317000209 |
Schlagwort: |
|
Sonstiges: |
|